Indaptus Therapeutics Inc (INDP)
2.47
+0.03
(+1.23%)
USD |
NASDAQ |
Jun 14, 16:00
2.42
-0.05
(-2.02%)
After-Hours: 20:00
Indaptus Therapeutics Shareholders Equity (Quarterly): 9.361M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 9.361M |
December 31, 2023 | 12.08M |
September 30, 2023 | 15.33M |
June 30, 2023 | 18.63M |
March 31, 2023 | 21.19M |
December 31, 2022 | 24.63M |
September 30, 2022 | 27.57M |
Date | Value |
---|---|
June 30, 2022 | 30.41M |
March 31, 2022 | 33.36M |
December 31, 2021 | 35.90M |
September 30, 2021 | 38.08M |
June 30, 2021 | 13.94M |
December 31, 2020 | -0.2377M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-0.2377M
Minimum
Dec 2020
38.08M
Maximum
Sep 2021
21.56M
Average
21.19M
Median
Mar 2023
Shareholders Equity (Quarterly) Benchmarks
Oragenics Inc | 2.625M |
Rezolute Inc | 70.86M |
GT Biopharma Inc | 5.312M |
IGM Biosciences Inc | 161.25M |
180 Life Sciences Corp | -0.9545M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 10.95M |
Total Liabilities (Quarterly) | 1.588M |